Giantonio, Bruce J.

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Giantonio, B. J., Catalano, P. J., Meropol, N. J., O'Dwyer, P. J., Mitchell, E. P., Alberts, S. R., Schwartz, M. A., & Benson, A. B. (2007) · Journal of Clinical Oncology

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 2,279

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Parikh, A. R., Leshchiner, I., Elagina, L., Goyal, L., Levovitz, C., Siravegna, G., Livitz, D., Rhrissorrakrai, K., Martin, E. E., Van Seventer, E. E., et al. (2019) · Nature Medicine

Cancer Genomics and DiagnosticsColorectal Cancer Treatments and Studies

Cited by 518

A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes

Boursi, B., Finkelman, B., Giantonio, B. J., Haynes, K., Rustgi, A. K., Rhim, A. D., Mamtani, R., & Yang, Y.-X. (2017) · Gastroenterology

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 202

Phase II study of topotecan in metastatic hormone-refractory prostate cancer

Hudes, G. R., Kosierowski, R., Greenberg, R., Ramsey, H. E., Fox, S. C., Ozols, R. F., McAleer, C. A., & Giantonio, B. J. (1995) · Investigational New Drugs

Prostate Cancer Treatment and ResearchCancer therapeutics and mechanisms

Cited by 32

A clinical prediction model to assess risk for pancreatic cancer among patients with pre-diabetes

Boursi, S. B., Finkelman, B., Giantonio, B. J., Haynes, K., Rustgi, A. K., Rhim, A., Mamtani, R., & Yang, Y.-X. (2018) · Journal of Clinical Oncology

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 3